1. Home
  2. JYNT vs ACHV Comparison

JYNT vs ACHV Comparison

Compare JYNT & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$8.72

Market Cap

149.5M

Sector

Miscellaneous

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.92

Market Cap

239.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JYNT
ACHV
Founded
2010
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.5M
239.0M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
JYNT
ACHV
Price
$8.72
$4.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$17.00
$15.50
AVG Volume (30 Days)
95.5K
589.5K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$54,176,002.00
N/A
Revenue This Year
$6.11
N/A
Revenue Next Year
$6.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.47
N/A
52 Week Low
$7.50
$1.84
52 Week High
$13.47
$5.78

Technical Indicators

Market Signals
Indicator
JYNT
ACHV
Relative Strength Index (RSI) 47.79 59.83
Support Level $8.65 $4.30
Resistance Level $8.90 $4.95
Average True Range (ATR) 0.26 0.24
MACD -0.03 0.03
Stochastic Oscillator 39.73 91.72

Price Performance

Historical Comparison
JYNT
ACHV

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Share on Social Networks: